US halts plasma study to treat mild COVID-19 citing 'unlikely benefit'

The National Institutes of Health announced Tuesday it stopped a clinical trial testing convalescent plasma in mild-to-moderate COVID-19 patients after an independent board found no difference in hospitalizations, deaths or in preventing progression to severe illness.

from FOX News https://ift.tt/2NVvuKA